Fact CheckerSign in

NCT07067047Completed

The Effect of Nursing Care Decision Support System Designed for Fluid Volume Excess of Patients With Heart Failure on Clinical Outcomes of Patients and Home Self-Care Outcomes

Source: ClinicalTrials.gov · Last updated 15 Jul 2025

Brief summary (registry, in English)

This study aims to evaluate the effects of a nursing care decision support system designed to reduce fluid overload in patients with heart failure. The goal is to examine its impact on clinical outcomes both during hospitalization and after discharge at home. The study focuses on improving nursing interventions and patient follow-up through structured, evidence-based decision-making tools.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
4 Jul 2025
Start date
1 Sept 2024
Primary completion date
31 Mar 2025
Lead sponsor
Leyla Biçen
NCT number
NCT07067047

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Sept 2024 to the primary completion date, 31 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of additional comorbidities other than cardiac risk factors (e.g., dialysis-dependent renal failure, lymphedema, oncology patients, etc.)
  • History of amputation
  • Isolated right heart failure
  • Development of poor general condition during follow-up
  • Extended hospitalization due to infection or other secondary causes

Other

  • Presence of severe valvular stenosis
  • Classified as morbidly obese
  • Inadequate cooperation or communication skills
  • Terminal stage patients
  • Absence of echocardiographic evaluation
  • BNP level not measured
    • Criteria for Discontinuation During the Study:
  • Inaccessible by phone
  • Withdrawal of consent
  • Transferred to intensive care units during follow-up

Who the study is looking for

  • Diagnosed with heart failure (HF)
  • Aged 18 years or older
  • Ejection fraction below 50%
  • Presence of +1 or greater pitting edema in the extremities
  • Voluntary agreement to participate in the study
  • Sufficient cognitive and communicative ability to participate in interviews and complete scales/forms

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
İzmir Katip Çelebi University Atatürk Training and Research Hospital
Coordinator of this site? Confirm its status
IzmirTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.